Literature DB >> 21321085

Regulation of mTORC1 complex assembly and signaling by GRp58/ERp57.

Iliana Ramírez-Rangel1, Ismael Bracho-Valdés, Aleida Vázquez-Macías, Jorge Carretero-Ortega, Guadalupe Reyes-Cruz, José Vázquez-Prado.   

Abstract

The mammalian target of rapamycin (mTOR) regulates cell growth and survival via two different multiprotein complexes, mTORC1 and mTORC2. The assembly of these serine-threonine kinase multiprotein complexes occurs via poorly understood molecular mechanisms. Here, we demonstrate that GRp58/ERp57 regulates the existence and activity of mTORC1. Endogenous mTOR interacts with GRp58/ERp57 in different mammalian cells. In vitro, recombinant GRp58/ERp57 preferentially interacts with mTORC1. GRp58/ERp57 knockdown reduces mTORC1 levels and phosphorylation of 4E-BP1 and p70(S6K) in response to insulin. In contrast, GRp58/ERp57 overexpression increases mTORC1 levels and activity. A redox-sensitive mechanism that depends on GRp58/ERp57 expression activates mTORC1. Although GRp58/ERp57 is known as an endoplasmic reticulum (ER) resident, we demonstrate its presence at the cytosol, together with mTOR, Raptor, and Rictor as well as a pool of these proteins associated to the ER. In addition, the presence of GRp58/ERp57 at the ER decreases in response to insulin or leucine. Interestingly, a fraction of p70(S6K), but not 4E-BP1, is associated to the ER and phosphorylated in response to serum, insulin, or leucine. Altogether, our results suggest that GRp58/ERp57 is involved in the assembly of mTORC1 and positively regulates mTORC1 signaling at the cytosol and the cytosolic side of the ER.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321085      PMCID: PMC3126338          DOI: 10.1128/MCB.00824-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

Review 1.  Interaction of ERp57 and tapasin in the generation of MHC class I-peptide complexes.

Authors:  Natalio Garbi; Günter Hämmerling; Satoshi Tanaka
Journal:  Curr Opin Immunol       Date:  2006-12-05       Impact factor: 7.486

Review 2.  What controls TOR?

Authors:  Estela Jacinto
Journal:  IUBMB Life       Date:  2008-08       Impact factor: 3.885

3.  The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.

Authors:  Yasemin Sancak; Timothy R Peterson; Yoav D Shaul; Robert A Lindquist; Carson C Thoreen; Liron Bar-Peled; David M Sabatini
Journal:  Science       Date:  2008-05-22       Impact factor: 47.728

4.  Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB.

Authors:  Shailly Varma; Ramji L Khandelwal
Journal:  Biochim Biophys Acta       Date:  2006-08-01

5.  The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C.

Authors:  Valeria Facchinetti; Weiming Ouyang; Hua Wei; Nelyn Soto; Adam Lazorchak; Christine Gould; Carolyn Lowry; Alexandra C Newton; Yuxin Mao; Robert Q Miao; William C Sessa; Jun Qin; Pumin Zhang; Bing Su; Estela Jacinto
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

6.  Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling.

Authors:  Tsuneo Ikenoue; Ken Inoki; Qian Yang; Xiaoming Zhou; Kun-Liang Guan
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

Review 7.  ER chaperones in mammalian development and human diseases.

Authors:  Min Ni; Amy S Lee
Journal:  FEBS Lett       Date:  2007-04-25       Impact factor: 4.124

Review 8.  The ERp57/GRp58/1,25D3-MARRS receptor: multiple functional roles in diverse cell systems.

Authors:  R C Khanal; I Nemere
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

9.  Phospho-proteomic approach to identify new targets of leucine deprivation in muscle cells.

Authors:  Jérémie Talvas; Alain Obled; Thierry Sayd; Christophe Chambon; Sylvie Mordier; Pierre Fafournoux
Journal:  Anal Biochem       Date:  2008-07-09       Impact factor: 3.365

10.  P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration.

Authors:  Ivette Hernández-Negrete; Jorge Carretero-Ortega; Hans Rosenfeldt; Ricardo Hernández-García; J Victor Calderón-Salinas; Guadalupe Reyes-Cruz; J Silvio Gutkind; José Vázquez-Prado
Journal:  J Biol Chem       Date:  2007-06-12       Impact factor: 5.157

View more
  24 in total

1.  Protein disulfide isomerase is required for platelet-derived growth factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation.

Authors:  Luciana A Pescatore; Diego Bonatto; Fábio L Forti; Amine Sadok; Hervé Kovacic; Francisco R M Laurindo
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

Review 2.  The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.

Authors:  Jianling Xie; Terence P Herbert
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

3.  A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis.

Authors:  Naiara Santana-Codina; Rafael Carretero; Rebeca Sanz-Pamplona; Teresa Cabrera; Emre Guney; Baldo Oliva; Philippe Clezardin; Omar E Olarte; Pablo Loza-Alvarez; Andrés Méndez-Lucas; Jose Carlos Perales; Angels Sierra
Journal:  Mol Cell Proteomics       Date:  2013-04-26       Impact factor: 5.911

Review 4.  Mammalian TOR signaling to the AGC kinases.

Authors:  Bing Su; Estela Jacinto
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-10-10       Impact factor: 8.250

Review 5.  Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics.

Authors:  Muireann Ní Bhaoighill; Elaine A Dunlop
Journal:  Cancer Drug Resist       Date:  2019-12-19

Review 6.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Authors:  Aubryanna Hettinghouse; Ronghan Liu; Chuan-Ju Liu
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

Review 7.  The impact of biosampling procedures on molecular data interpretation.

Authors:  Karl Sköld; Henrik Alm; Birger Scholz
Journal:  Mol Cell Proteomics       Date:  2013-02-04       Impact factor: 5.911

8.  ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer.

Authors:  Min Ho Choe; Joong Won Min; Hong Bae Jeon; Dong-Hyung Cho; Jeong Su Oh; Hyun Gyu Lee; Sang-Gu Hwang; Sungkwan An; Young-Hoon Han; Jae-Sung Kim
Journal:  Oncotarget       Date:  2015-02-20

9.  Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma Tumor Cells.

Authors:  Jun Luo; Yoshinobu Odaka; Zhu Huang; Bing Cheng; Wang Liu; Lin Li; Chaowei Shang; Chao Zhang; Yang Wu; Yan Luo; Shengyong Yang; Peter J Houghton; Xiaofeng Guo; Shile Huang
Journal:  Cells       Date:  2021-06-01       Impact factor: 7.666

10.  Identification and characterisation of the RalA-ERp57 interaction: evidence for GDI activity of ERp57.

Authors:  Adam Brymora; Iain G Duggin; Leise A Berven; Ellen M van Dam; Basil D Roufogalis; Phillip J Robinson
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.